Only 4 New Alzheimer’s Drugs in 20 Years? Here’s Why That’s a Crisis
Explore the alarming stagnation in Alzheimer’s drug approvals and the systemic flaws hindering breakthroughs in treatment.
drug approval
Only 1 Drug Approved in 20 Years: What’s Holding Back Alzheimer’s Research?
By Dana Kim, Crypto Markets Analyst Last updated: April 26, 2026 Only 1 Drug Approved in 20 Years: What’s Holding Back Alzheimer’s Research? Over the past 20 years, only one drug for Alzheimer’s disease has gained FDA approval, a shocking figure given the escalating costs and urgent need for effective treatments. The financial intensity of … Read more